Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden

Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden

AbstractAims To estimate healthcare resource use and direct healthcare costs of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Sweden over 12 months across severity stages as defined by the New York Heart Association (NYHA). Secondary to investigate the current diagnostic trajectory for patients...

Full description

Bibliographic Details
Main Authors: Frida Hjalte, Jenny M. Norlin, Linda Alverbäck-Labberton, Katarina Johansson, Gerhard Wikström, Per Eldhagen
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
ATTR-CM
costs
diagnosis
health care resources
NYHA
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2292686

Similar Items

Similar Items